[1]
Zhao, S.H.; Zhang, Q.X. The resources of Pyrola and the prospect of its landscape applications in Beijing. Zhongguo Yuanlin, 2003, 74-76.
[2]
Liu, C.H.; Ai, Q.J. Overview of research of Pyrola calliantha H.Andres J. Indl. Tech. Eco.,, 1994, (6), 75-76.
[3]
Zhang, Y.Y.; Chen, X.H.; Jin, Z.S.; Bi, K.S. Chemical constituents of Pyrola decorata II. Zhongguo Shiyan Fangjixue Zazhi, 2012, 18(1), 96-98.
[4]
Zheng, S.J.; Yang, D.D.; Zhu, R.; Yang, S.X.; Gao, Y.H. Isolation and identification of chemical components from Pyrola calliantha. Chem. Bioeng., 2016, 33(12), 31-33.
[5]
Pan, W.W.; Pei, G.; Wang, Y.M.; Liu, Y.Q.; Liu, M.; He, W.J.; Zhou, X.J. Studies on the chemical constituents isolated from Pyrola calliantha. Xibei Yaoxue Zazhi, 2014, 29(3), 221-222.
[6]
Zhang, Y.Y.; Chen, X.H.; Jin, Z.S.; Bi, K.S. Chemical constituents of Pyrola decorata I. Zhongguo Shiyan Fangjixue Zazhi, 2011, 17(20), 114-117.
[7]
Wu, Y.S.; Li, C.X.; Lin, Y.; Huang, Y.M.; Huang, M.Y.; Lin, Y.P.; Ye, H.Z. Chemical composition of Chinese Pyrola Herb volatile and the effects on the osteoblast proliferation. World J. Integr. Trad. Western Med., 2016, 11(4), 492-495.
[9]
Luo, W.Q.; Wang, H.D.; Liu, C.H. Study on chemical composition in Pyrola Rotundifolia. J. Ankang Teac. Col., 2002, 14(1), 56-57.
[11]
Ai, Q.J.; Yu, Q.H.; Zhang, H.X.; Wu, X.H.; Wang, X.D.; Li, Q. Studies on bacteriostatic action and antimicrobial mechanism of pyrolin against staphylococcus aureus. Zhongguo Shipin Xuebao, 2007, 7(2), 33-37.
[12]
Duan, J.Y.; Wen, G.; Liu, X.Y. The anti-inflammatory effect of
Pyrola. Shanxi J. Trad. Chin. Med, 1992, 42-43.
[14]
Zhang, L.; Wang, Z.Q.; Song, L.; Yang, J.H.; You, X.J.; Yang, Y.J.; Wang, J.X. Study on effective parts of the action of Pyrola on lowering blood lipid. Northwestern J. Pharm., 2010, 25(3), 195-196.
[15]
He, X.Q.; Ye, M.L.; Gu, Y.Q.; Shao, X.Y.; Chen, X.; Hou, Y.L.; Qiao, G.F. The effect and mechanism of herba Pyrolae flavonoid glycoside on the rat thoracic aorta in vitro. Shi Zhen Guo Yi Guo Yao, 2010, 21(4), 900-902.
[16]
Xuan, W.J.; Dong, M.S.; Li, Q.M. Experimental study on the antagonistic effects of compound Astragalus membranaceus (Fisch.) Bunge. injection on gentamicin nephrotoxicity. Guangxi Med. J., 1995, 17(1), 17-19.
[17]
Zhang, L.; Yu, Y.M.; Wang, J.X.; Pang, Z.G. A survey of the studies on the mechanism of Pyrola. Northwestern J. Pharm., 1998, 13(6), 270-271.
[19]
Liu, Y.; Li, W.H.; Zhai, G.S.; Liu, J.; Ju, Y.H.; Chang, L.; Qin, J.Y. Study on radioprotective effect of ethanol extract of Pyrola on mice. World Clin. Drugs, 2013, 34(1), 30-34.
[20]
Li, G.H.; Sun, J.Y.; Zhang, X.L.; Yang, Z.N.; Zhou, C.; Yang, S.B. Experimental studies on antihyperlipidemia effects of two compositions from hawthorn in mice. Chin. Tradit. Herbal Drugs, 2002, 33(1), 50-52.
[22]
Wang, C.Y.; Ai, Q.J.; Du, M.Y.; Chen, X. Study on antimicrobial properties of Pyola calliantha extracts and application in strawberry preservation. Shipin Kexue, 2008, 29(1), 325-328.
[23]
Sun, C.Y.; Chen, Z.; Wang, W.W.; Li, Y.; Dong, Y.L.; Wang, L.J. Research on the development and utilization of Pyrola resources. Beifang Yuanyi, 2011, (1), 220-222.
[24]
Ma, Y.X.; Cui, D.L.; Wang, S.Z. Application of Pyrola dahurica (H. Andr.) Kom. on northern landscaping. Heilongjiang Nongye Kexue, 2009, (6), 101-102.
[26]
Namba, T. Encyclopedia of chinese medicine; China Medical Science Press: Beijing, 2001.
[29]
Editorial Committee of Flora of China. Flora of China., Science Press: Beijing,. 2015.
[30]
Editorial Committee of Chinese Pharmacopoeia. Chinese Pharmacopoeia,, 10th ed; China Medical Science Press: Beijing,. 2015.
[31]
Cai, G.R.; Zhang, G. Advances in domestic clinical research of Yan Lu Ru Kang Jiao Nang. Chin. J. Fam. Plann., 2017, 25(12), 888-890.
[32]
Zhao, Y.; Wang, Y.; Zheng, J.F.; Ding, Y.; Li, W.L. Study on the quality standard for Teng Huang Jian Gu Pills. China Pharmacist, 2013, 16(1), 76-80.
[33]
Wang, J.H. Determination of critical relative humidity of compound Pyrola capsules. Zhongguo Yiyuan Yongyao Pingjia Yu Fenxi, 2008, 8(6), 444.
[34]
Zhang, Y.W.; Wang, Y.Y.; Wang, Y.F.; Zhang, K.L. Quality control of Fu Fang Lu Jiao Shuang Tablet. Herald of Medicine, 2015, 34(12), 1644-1648.
[35]
Guo, H.Q. Clinical treatment of calcaneodynia. Clin. Health Care of Chin. Med., 1993, 5(1), 52-54.
[36]
Han, Z.Z.; Han, X.R.; Zhu, L.Q.; Lin, G.T.; Sheng, H.G. Study on the quality standard of Guan Jie Kang Capsules. J. Shandong Uni. Trad. Chin. Med., 2018, 42(1), 78-82.
[37]
Lian, M.S.; Cao, W. Decoction cured 32 cases of acute nephritis. J. Sichuan Trad. Chin. Med., 1987, 8, 15.
[38]
Wu, M. 48 cases of perimenopausal uterine bleeding treated with Si Cao Decoction. Shaanxi J. Trad. Chin. Med., 2005, 26(5), 388-389.
[39]
Wu, J.; Zhou, Z.Q.; Zhou, D.H. Clinical observation of 37 cases of rheumatoid arthritis with heat depression treated with Jia Wei Si Cao Decoction. J. New Chin. Med, 2010, 42(11), 56-57.
[40]
Xie, H.R.; Liu, H. 258 cases of chronic prostatitis treated with Hu Lu Wu Shen Si Zi Decoction. Shaanxi J. Trad. Chin. Med., 2004, 25(4), 308-309.
[41]
Tian, Y.P.; Li, L.S.; Dong, T.C.; Chen, X.B.; Liu, J.R. 130 cases of angina pectoris treated with Xin Fu Ning V. Shannxi J. Trad. Chin. Med., 2010, 31(10), 1282-1283.
[42]
Xu, B.; Han, J. Study on the quality standard of Juan Bi Kang Sheng Pill. Chin. J. Trad. Med. Sci.Tech., 2014, 21(3), 269-271.
[43]
Zhang, S.X.; Yang, J.; Wang, X.N.; Zhang, B. TLC identification of Pyrola and Uncaria rhynchophylla in Jing Kang Tablet. Zhongchengyao, 2008, 30(7), 1869-1872.
[44]
Wei, X.Y. 80 cases of spleen and kidney deficiency type of avulsion treated with self-designed Fu Fang Huang Qi Decoction. J. Guangxi Uni. Chin. Med., 2016, 19(2), 36-37.
[45]
Wei, R.X.; Tang, Y.J. 120 cases of chronic renal failure treated with Yi Shen Li Shi Pai Du Decoction. Chin. Man. Rehab. Med., 2012, 3(33), 183-184.
[46]
Wan, L.Z. 79 Cases of sciatica treated with Juan Tong Decoction. Shannxi J. Trad. Chin. Med.,,, 1988, (10), 448.
[47]
Zheng, Y.J. 24 cases of dry sciatica treated with Si Chong Juan Bi
Decoction. J. New. Chin. Med,,, 1990, (12), 39.
[48]
Li, Y.W. 30 cases of knee osteoarthritis were treated with kidney-tonifying and collaterals activating method. Shannxi J. Trad. Chin. Med., 2007, 28(12), 1614-1615.
[49]
Zhou, F.F.; Wen, L.; Zhu, X.S. A summary of 94 cases of chronic ulcerative colitis treated by combination of acupuncture and medicine. Hunan J. Trad. Chin. Med., 1997, 13(5), 18-19.
[50]
Yu, H.M. Acupuncture combined bu shen yi jing decoction treatment of ankylosing spondylitis random parallel control study. J. Prac. Trad. Chin. Inter. Med., 2013, 27(4), 148-150.
[51]
Zhu, H.J. Clinical research of psoriatic arthritis treated by the integration of traditional chinese medicine and western medicine. J. Chin. Med., 2012, 27(12), 1644-1645.
[52]
Liu, S.S.; Rao, S.H. Treatment of 50 cases of dizziness with ludan reading pills. Shannxi J. Trad. Chin. Med., 2009, 30(4), 461-461.
[53]
Chen, Y.J. Clinical analysis of 600 cases of breast disease treated by ruhesanjie tablets. Med. Inform., 2009, 1(6), 135-136.
[54]
Liao, C.J. Curative effect observation on 81 cases of acute gouty arthritis with Sanmiao San plus probenecid. New J. Trad. Chin. Medi., 2005, 37(7), 31-32.
[55]
Han, Z.H. Analysis of curative effect of 20 cases of heel spurs treated by Simiao decoction. Shanghai Med. & Pharma. J., 2012, 33(16), 28-29.
[56]
Li, F.; Zhao, Q.; Meng, L.F. Treatment of 30 cases of lumbar intervertebral disc protrusion with yaotongkang I capsules. Shannxi J. Trad. Chin. Med., 2008, 29(8), 991-992.
[57]
Wang, C. Treatment of skeletal fluorosis. Hebei Med. J., 1989, 4(12), 226-227.
[58]
Li, L.S.; Liu, J.R.; Dong, T.C.; Lan, Y.X.; Xu, M.N.; Hou, J.W. Treatment of 56 cases of coronary heart disease and angina pectoris with guanxinning. Shannxi J. Trad. Chin. Med., 2007, 28(10), 1275-1276.
[59]
Li, Y.L.; Pang, J.; Huang, L.; Li, J.S.; Liu, L.N.; An, H.W.; Yang, W.Q. A clinical study on oral solution of Huaixue Shenshu for treatment of patients with IgA nephropathy. Chinese J. Integr. Trad. Western Med. Intens. Critic. Care, 2015, 22(1), 55-58.
[60]
Zhang, Y.; Kuang, J.L.; Li, L. Clinical observation of Longmu capsule in treating prolonged menstruation caused by cesarean scar defect. Guangxi Zhongyiyao, 2017, 40(4), 7-9.
[61]
Zhao, L.; Yao, Y.M.B. Shanghai Scientific & Technical Publishers:
Shanghai, , 1959; 77., .
[62]
Sun, Y.M. Clinical Cases and Prescription; Henan Science and Technology Publishing House: Henan, 1981.
[63]
Zhai, C.Y. Treating 38 cases of chronic nephritis with Fu fang San Cao Decoction. Clin. J. Chin. Med., 2011, 3(18), 57-57.
[64]
Sheng, H.G. Advances in research of chemical constituents and pharmacological actions of Pyrola herba. Xibei Yaoxue Zazhi, 2012, 27(4), 383-385.
[65]
Shi, J.; Wang, J.X. Study on the chemical constituents of Pyrola calliantha. Nat. Prod. Res. Develop., 2002, 14(1), 37-38.
[66]
Luo, D.Q.; Yang, Y.Z.; Song, L.; Wang, J.X. Advances in studies on special plants of Pyrola L. in China. Chin. Tradit. Herbal Drugs, 2004, 34(4), 463-466.
[67]
Wang, J.X.; Chen, X.M.; Li, H.; Yang, L.; Yu, W.S. Chemical constituents of Pyrola calliantha H. Andres: the structure and identification of hydroxylrenifolin. Acta Bot. Sin., 1994, 36(11), 895-897.
[68]
Zhou, Y.B.; Du, X.Y.; Wang, J.H.; Li, X. Chemical constituents of Pyrola chlorantha Sw. J. Shenyang Pharm. Univ., 2009, 26(1), 19-22.
[70]
Li, D.; Yang, S.; Song, B.A.; Jiang, L.K.; Hu, D.Y.; Xue, W. Research advances on Pyrola L. J. Guizhou Uni. Nat. Sci., 2008, 25(2), 188-194.
[74]
Bian, X.L.; Liu, C.B.; Deng, X.L.; Qiu, P.L.; Wang, J.X. Protective effect of galloylhyperin on ischemia and reperfusion of rat heart. J. Xi’an Medi. Uni. Med. Sci., 1998, 19(3), 399-401.
[75]
Huang, K.; Yang, X.B.; Huang, Z.M. Advances of the hyperin pharmacology research. Herald Med., 2009, 28(8), 1046-1048.
[76]
Ren, F.X.; Zhang, A.J.; Zhao, Y.M. Study on the chemical constituents of Pyrola calliantha H. Andres. Nat. Prod. Res. Develop., 2010, 22(1), 54-57.
[77]
Zhang, Y.Y.; Huo, Y.S.; Chen, X.H.; Bi, K.S. Simultaneous determination of 3 phenolic compounds in Pyrola decorate by RP-HPLC. Lishizhen Med. Mater. Medica. Res., 2011, 22(1), 251-252.
[78]
Liu, R.X.; Zhang, Y.J.; Li, B.J.; Feng, D.L.; Zheng, W.T.; Zhan, H.X.; Lv, Y.G. Determination of the arbutin contents of Pyrola rotundifolia L in the northeast region. Heilongjiang Med. Sci., 2013, 36(2), 26-27.
[79]
Lei, M.M. Research progress of new chemical constituents and extraction methods from Pyrola herba. Stud. Trace Elem. Health, 2018, 35(3), 43-45.
[80]
Xu, W.F.; Li, X.C.; Dong, J.D.; Deng, S.H. Study of antibacterial efficacy of Luticaosu in vivo and vitro. J. Shandong Uni., 1996, 34(3), 252-254.
[81]
Wang, X.F.; Zhang, J.M.; Cao, A.L.; Ma, G.E.; Li, H.Y.; Yang, B.J. Chemical constituents of the Chinese Pyrola. Chin. Herb. Med., 1988, (1), 8-10.
[85]
Zhao, M.; Wu, L.; An, J.S.; Qiu, Z.D.; Meng, Q.F. Quality standard for Pyrola dispensing granules. Zhongchengyao, 2013, 35(1), 148-150.
[86]
Ren, F.X.; Zhang, A.J.; Zhao, Y.M. Studies on chemical constituents of Pyrola calliantha H. Andres II. Pharm. J. Chin. Peop. Liber. Army, 2008, 24(4), 301-304.
[88]
Dong, J.J.; Zhang, J.; Liu, J.; Yang, Y. Compare the extraction methods of Pyrola polysaccharide. China J. Chin. Med., 2015, 30(8), 1173-1175.
[89]
Yu, C.L. Amino acids and human health. Amino acids & biotic res.,, 1999, 21(4), 4-8.
[90]
Wang, C.Y.; Ai, Q.J.; Chen, X.; Zhang, W. The chemical components,physiological functions and the application of Pyrola calliantha.China Food Addit, 2006, (5), 127-131.
[91]
Lee, M.H.; Lee, J.M.; Jun, S.H.; Lee, S.H.; Kim, N.W.; Lee, J.H.; Ko, N.Y.; Mun, S.H.; Kim, B.K.; Lim, B.O.; Choi, D.K.; Choi, W.S. The anti-inflammatory effects of Pyrolae herba extract
through the inhibition of the expression of inducible nitric oxide
synthase (iNOS) and NO production. J. Ethnopharmacol, 2007, 112(1), 0-54.
[94]
Liu, W.B.; Zhou, N.; Yang, X.M.; Yang, X.Y.; Wang, Y.H.; Du, G. Tumor necrosis factor-α inhibitor high-throughput drug screening
model for drug screening in vitro experiments Chinese J. Emergency Resus. Disaster med.,, 2012, 7(9)
[99]
Bian, X.L.; Pan, Q.; Dong, J. The antioxidativity of 2′-O-galloy-3-β-galactosyloxy quercetin and the structure-activity relationships. J. Xi’an Jiaotong Uni., 2003, 24(5), 452-454.
[100]
Yang, D.Z.; Li, S.M. Preliminary study on the water extract of Pyrola rotundifolia L. Inform. Trad. Chin. Med.,, 1987, (6), 39-42.
[101]
Zhou, Y.B.; Zhao, X.H.; Ai, Q.J. Inhibitory effect and antimicrobial mechanism of three kinds of Chinese herbal medicine on escherichia coli. Zhongguo Nongxue Tongbao, 2014, 30(21), 294-300.
[102]
Zhang, W.; Ai, Q.J.; Wu, X.H. Studies on inhibitory effects in-vitro of pyrolin against postharvest pathogenic fungi from fruits and vegetables. J. Beijing Uni. Agri., 2007, 22(2), 47-50.
[103]
Wu, Z.Y.; Wang, Y.; Ai, Q.J. Inhibitory effect and antimicrobial mechanism of pyrolin on monilinia cticolain peach. Chin. Acad. Agri. Sci., 2009, 42(1), 325-328.
[104]
Zhang, W.; Ai, Q.J.; Wu, Z.Y.; Wei, Y.Q. Inhibitory effect of pyrolin on alternaria alternata causing occurrence of black spot in postharvest pear. Guoshu Xuebao, 2008, 25(5), 755-759.
[105]
Hu, M. Study on the bacteriostatic action and mechanism of the aqueous extract of herbe Pyrolae on enterococcus faecalis., MF
Thesis, Guangxi University: Guangxi,. 2018., 12-53.
[107]
Tian, Y.X. Research and application of Pyrola. Mod.Trad. Chin.Med., 1998, (5), 1-2.
[108]
Qing, S.Y.; Liu, W.; Zhang, Y.Y.; Chen, X.H.; Lao, J.; Bi, K.S. Preliminary study on the anti-tumor effect of the extracts of four traditional Chinese medicines. Northwestern J. Pharm., 2007, 22(1), 16-18.
[109]
Yuan, Z.Z.; Cao, Z.W.; Lin, S.S.; Ye, R.; Dan, Z.S. Inhibitory action of pyrite or Pyrola on nude mouse with bone metastasis in lung cancer. Zhonghua Zhongyiyao Xuekan, 2012, 30(12), 2723-2725.
[110]
Cai, L.L.; Yu, F.R.; Chen, J.S.; Li, H.T.; Ye, H.Z.; Lin, Y.P.; Liu, X.X. Study on mechanism of Pyrolae herb essential oil inducing apoptosis in human chondrosarcoma SW1353 cells. Zhonghua Zhongyiyao Zazhi, 2014, 29(4), 1085-1088.
[114]
Wu, Y.S.; Huang, M.Y.; Chen, X.Z.; He, J.C.; Lin, Y.; Lin, Y.P. Effects of different polar fractions on the proliferation of osteoblasts. Chinese J. Trad. Med. Traum. Orthop., 2010, 18(9), 4-6.
[115]
Ma, Z.Y. Effects of Chinese herbal formulations such as Pyrola on
cellular immune function. Shaanxi new artisan medicine, 1984, 56-57.
[116]
Wang, X.L.; Wang, J.X.; Yu, Y.M.; Guo, W.J. Overview of clinical research in herba Pyrolae. Shannxi J. Trad. Chin. Med., 2000, 21(1), 45-46.
[117]
Zhou, F.C. Pyrola herb and food therapy. Food Ind., 2017, (9), 79-79.
[118]
Yang, X.L.; Lin, Z.H.; Sheng, Z.Z.; Yang, F.; Xu, B.; Lu, K.J.; Yuan, Q.; Hu, X.M. Protective effect of Pyrola decorata H.Andres on β-amyloid protein-induced cytotoxicity in PC12 cells. Herald of Medicine, 2016, 35(9), 947-951.
[119]
Cheng, L. Study on extraction of total flavones of herba Pyrolae and its effects on coronary blood flow in dogs., MF Thesis, Xi'an
Jiaotong University: Xi'an,. 2003., 25-26.